19
Uterine artery embolisation Nick Harper 4 th yr SSC

Uterine artery embolisation

Embed Size (px)

Citation preview

Page 1: Uterine artery embolisation

Uterine artery embolisation

Nick Harper4th yr SSC

Page 2: Uterine artery embolisation

• Asymptomatic• Heavy uterine bleeding• Pain• Dyspareunia• Pressure symptoms

Uterine Leiomyomas - Fibroids

• Benign monoclonal tumours

• 9% of women < 44 years old

• 40% of women > 40 years old

Page 3: Uterine artery embolisation
Page 4: Uterine artery embolisation

• Myomectomy• 35,000 a year (US)

• Hysterectomy– 300,000 a year (US)

NICE: Symptomatic Fibroid(s) >3cm:

• Gonadotrophin releasing hormone (GnRH) analogue

• Uterine artery embolisation

Page 5: Uterine artery embolisation
Page 6: Uterine artery embolisation

Uterine artery embolisation• Day case• Sedation – Diazemuls (5mg/min IV infusion)• Analgesia - Paracetamol (500mg IV)• Local anaesthesia - Lidocaine

• Morphine (5mg IV)

• Metoclopramide (10mg IV)

Page 7: Uterine artery embolisation

Seldinger technique

1.

2.

3.

4.

Page 8: Uterine artery embolisation
Page 9: Uterine artery embolisation
Page 10: Uterine artery embolisation

•Polyvinyl alcohol (PVA) particles•Trisacryl gelatin microspheres•Gelatin sponge

•Preferential flow to fibroid vessels

Page 11: Uterine artery embolisation
Page 12: Uterine artery embolisation
Page 13: Uterine artery embolisation

Evidence Base

• Introduced in 1997

• 4 RCTs (n= 403)

• 1 Comparative study

• 3 Case series

• UK registry (n= 1387)

• US registry (n= 2112)

Page 14: Uterine artery embolisation

• SymptomsSymptoms improved in 85 – 95% of patients

• 30 – 48% decrease in fibroid volumefibroid volume (all studies)

• Improved quality of life quality of life 39/100 (US registry n=2112)

• 91% would recommendrecommend to a friend (HOPEFUL n=649)

• 90% < 2 nights 2 nights in hospital (Gabriel-Cox n=562)

Efficacy

Page 15: Uterine artery embolisation

Complications

Procedure •Early: 6.9% (Mara n=58)

•1st month: 20.7% (Mara n=58)

•1 year: 17.6% (HOPEFUL 649)

Non target emboli•Amenorrhea•Buttock/Bladder•1 death(Goodwin 2009)

Failure•11% required further treatment (UK registry n= 1387)

Fertility •27 women •37 pregnancies •19 live births (HOPEFUL n= 649)

Page 16: Uterine artery embolisation
Page 17: Uterine artery embolisation
Page 18: Uterine artery embolisation

References• Dutton S, Hirst A, McPherson K, et al. (2007) A UK multicentre retrospective cohort study comparing

hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids (HOPEFUL study): main results on medium-term safety and efficacy. BJOG 114: 1340–51.

• Edwards RD, Moss JG, Lumsden MA, et al. (2007) Uterine-artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine 356: 360–70.

• Gabriel-Cox K, Jacobson GF, Armstrong MA, et al. (2007) Predictors of hysterectomy after uterine artery embolization for leiomyoma. American Journal of Obstetrics & Gynecology 196: 588.e1–588.e6.

• Goodwin SC, Spies JB, Worthington-Kirsch R, et al. (2008) Uterine artery embolization for treatment of leiomyomata. Obstetrics & Gynecology 111; 22–33.

• Goodwin, S.C. & Spies, J.B. (2009) Uterine Fibroid Embolization. The New England Journal of Medicine. 361:690-697

• Gupta, J.K., Sinah, A., Lumsden, M.A. & Hickey, M. (2009) Cochrane Review – Uterine artery embolization for symptomatic fibroids. The cochrane collaboration.

• Hirst A, Dutton S, Wu O, et al. (2008) A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study. Health Technology Assessment 12 (5).

Page 19: Uterine artery embolisation

References• Mara M, Maskova J, Fucikova Z, et al. (2008) Midterm clinical and first reproductive results of a

randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular & Interventional Radiology 31: 73–85.

• Marshall LM, Spiegelman D, Barbieri RL, Manson JE, Colditz GA, Willett WC, et al.Variation in the incidence of uterine leiomyoma among pre menopausal women by age and race. Obstetrics & Gynecology 1997;90:967–73.

• Moss JG, Lumsden MA, Murray GD, et al. (2010) Long term (3-5 year) follow up and MRI imaging of the REST trial cohort. Unpublished personal communication.

• O’Grady EA, Moss JG, Belli AM, et al. (2009) UK uterine artery embolisation for fibroids registry 2003–2008. The British Society of Interventional Radiology.

• Spies JB, Bruno J, Czeyda-Pommersheim F, et al. (2005) Long-term outcome of uterine artery embolization of leiomyomata. Obstetrics & Gynecology 106: 933–9.

• Volkers NA, Hehenkamp WJK, Birnie E, et al. (2007) Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years’ outcome from the randomized EMMY trial. American Journal of Obstetrics & Gynecology 196: 519.e1–519.e11.

• Walker WJ, McDowell SJ. (2006) Pregnancy after uterine artery embolization for leiomyomata: a series of 56 completed pregnancies. American Journal of Obstetrics & Gynecology 195: 1266–71.